Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 600 09 033.7 |
96 | EP file number | EAKZ | 00 90 2358.1 |
86 | WO file number | WAKZ | PCT/US00/00411 |
97 | EP publication number | EPN | 1140936 |
87 | WO publication number | WPN | 2000042040 |
54 | Designation/title | TI | TRICYCLISCHE INHIBITOREN VON POLY(ADP-RIBOSE) POLYMERASEN |
51 | IPC main class | ICM (ICMV) | C07D 471/06 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07D 487/06 (2006.01), A61K 31/4375 (2006.01), A61K 31/55 (2006.01), A61K 31/551 (2006.01), A61P 35/00 (2006.01), C07D 519/00 (2006.01) |
22 | DE application date | DAT | Jan 10, 2000 |
96 | EP application date | EAT | Jan 10, 2000 |
86 | WO application date | WAT | Jan 10, 2000 |
43 | Date of first publication | OT | Jul 20, 2000 |
| Date of publication of grant | PET | Mar 17, 2004 |
71/73 | Applicant/owner | INH | Agouron Pharmaceuticals, Inc., La Jolla, Calif., US; Cancer Research Technology Ltd., London, GB |
72 | Inventor | IN | WEBBER Evan, Stephen, San Diego, US; CANAN-KOCH S., Stacie, La Jolla, US; TIKHE, Jayashree, San Diego, US; THORESEN Henrik,, Lars, College Station, US |
74 | Representative | VTR | Lederer & Keller Patentanwälte Partnerschaft mbB, 80538 München, DE |
10 | Published DE documents | DEPN | Original document:
DE000060009033T2 Searchable text:
DE000060009033T2 |
| Address for service | | Lederer & Keller Patentanwälte Partnerschaft mbB, 80538 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 115431 P Jan 11, 1999
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE |
| Published EP/WO documents | EPWOPN | Original document:
EP000001140936 Searchable text:
EP000001140936 Original document:
EP000001140936B1 Searchable text:
EP000001140936B1 Original document:
WO002000042040 Searchable text:
WO002000042040 |
43 | Date of first publication | EVT | Jul 20, 2000 |
| Date of the first transfer into DPMAregister | EREGT | Sep 29, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 14, 2020 (Show all update days)(Hide all update days)- Jan 14, 2020; Jan 11, 2019; Oct 22, 2018; Jan 18, 2018; Feb 9, 2017; Jan 20, 2017; Jan 26, 2016; Aug 25, 2015; Jan 23, 2015; Feb 11, 2014; Jan 28, 2014; Feb 9, 2013; Jan 19, 2013
- Historical data not available for this/these date(s)
- Sep 29, 2012
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 5)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Feb 11, 2004 |
71/73 | Applicant/owner | INH | Agouron Pharmaceuticals, Inc., La Jolla, Calif., US; Cancer Research Technology Ltd., London, GB |
71/73 | Previous applicant/owner | INHF | Agouron Pharmaceuticals, Inc., La Jolla, Calif., US, Cancer Research Campaign Technology Ltd., London, GB |